Tybourne Capital Management (Hk) Ltd / TSHA
Tybourne Capital Management (Hk) Ltd’s Taysha Gene Therapies Inc Position
Does Tybourne Capital Management (Hk) Ltd own Taysha Gene Therapies Inc (TSHA)? Yes — 3.70M shares worth $12M (+39.11% of its 13F portfolio) as of Q3 2025, down from 4.09M shares the prior filed quarter.
Position Value
$12M
Q3 2025
Shares
3.70M
% of Portfolio
+39.11%
Quarters Held
21
currently held
Position History TSHA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2025 | 3.70M | $12M | +39.11% |
| Q2 2025 | 4.09M | $9M | +27.39% |
| Q1 2025 | 3.70M | $5M | +21.83% |
| Q4 2024 | 3.70M | $6M | +1.61% |
| Q3 2024 | 3.70M | $7M | +2.08% |
| Q2 2024 | 3.70M | $8M | +1.69% |
| Q1 2024 | 3.70M | $11M | +1.82% |
| Q4 2023 | 3.70M | $7M | +0.98% |
| Q3 2023 | 1.50M | $5M | +0.66% |
| Q2 2023 | 1.50M | $991,500 | +0.11% |
| Q1 2023 | 1.50M | $1M | +0.12% |
| Q4 2022 | 1.50M | $3M | +0.34% |
| Q3 2022 | 500.0K | $965,000 | +0.09% |
| Q2 2022 | 500.0K | $2M | +0.13% |
| Q1 2022 | 500.0K | $3M | +0.19% |
| Q4 2021 | 500.0K | $6M | +0.17% |
| Q3 2021 | 500.0K | $9M | +0.23% |
| Q2 2021 | 500.0K | $11M | +0.22% |
| Q1 2021 | 500.0K | $10M | +0.22% |
| Q4 2020 | 500.0K | $13M | +0.28% |
| Q3 2020 | 500.0K | $11M | +0.28% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tybourne Capital Management (Hk) Ltd’s full portfolio or all institutional holders of TSHA.